GGAL Grupo Financiero Galicia S.A.
$35.14▼ -0.59%
Financials
Other
Volume 1.15M
Avg Volume (10D) 1.09M
Key Metrics & Fundamentals
Market Cap
$5.95B
P/E Ratio
39.5
Div Yield
4.38%
52W Range
33.66 - 62.52
% vs 50 MA
-12.10%
% vs 200 MA
-23.39%
RSI-14
38.8
MACD Histogram
+0.1900
Beta (1Y vs SPY)
1.70
Gross Rev
$2.77T
Gross Profit
$2.77T
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
$401.72B
Net Income
$258.32B
EPS (Diluted)
1608.23
Price & Volume History
Loading chart…
Recent News
Why Grupo Financiero Galicia ADR Crashed Today
Motley Fool · Oct 26, 2026 12:27 PM ET
Grupo Financiero Galicia (GGAL) Stock Sees Fair Value Cut As Analysts Turn More Cautious
Simply Wall St. · Oct 26, 2026 3:05 AM ET
Why Grupo Financiero Galicia Bears Were Right Before The Drop
Simply Wall St. · Oct 17, 2026 6:10 PM ET
GGAL or UOVEY: Which Is the Better Value Stock Right Now?
Zacks · Sep 21, 2026 11:40 AM ET
Wall Street Analysts Think Grupo Financiero Galicia (GGAL) Could Surge 44.82%: Read This Before Placing a Bet
Zacks · Sep 10, 2026 9:55 AM ET
GGAL vs. UOVEY: Which Stock Is the Better Value Option?
Zacks · Sep 3, 2026 11:40 AM ET
Stanley Druckenmiller Invested Tens of Millions Into These Risky Stocks. Should You?
Motley Fool · Sep 3, 2026 8:35 AM ET
Grupo Financiero Galicia SA (GGAL) (Q2 2026) Earnings Call Highlights: Net Income Rises 12% on ...
GuruFocus.com · Aug 26, 2026 7:01 PM ET
Grupo Financiero Galicia Q2 Earnings Call Highlights
MarketBeat · Aug 26, 2026 3:02 PM ET
Grupo Financiero Galicia: Q2 Earnings Snapshot
Associated Press · Aug 26, 2026 3:17 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GGAL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.